IGHG1 and Huntington disease: Our data showed a strong trend towards increased ALB in HD mutation carriers compared with controls (P = 0.068) and a significant increase of CSF IGHG1 (heavy chain constant domain of IgG) in the late HD compared with controls (P = 0.004).